Guidelines for case classification for the National Birth Defects Prevention Study.

BACKGROUND Previous studies have suggested that etiologic heterogeneity may complicate epidemiologic analyses designed to identify risk factors for birth defects. Case classification uses knowledge of embryologic and pathogenetic mechanisms to make case groups more homogeneous and is important to the success of birth defects studies. METHODS The goal of the National Birth Defects Prevention Study (NBDPS), an ongoing multi-site case-control study, is to identify environmental and genetic risk factors for birth defects. Information on environmental risk factors is collected through an hour-long maternal interview, and DNA is collected from the infant and both parents for evaluation of genetic risk factors. Clinical data on infants are reviewed by clinical geneticists to ensure they meet the detailed case definitions developed specifically for the study. To standardize the methods of case classification for the study, an algorithm has been developed to guide NBDPS clinical geneticists in this process. RESULTS Methods for case classification into isolated, multiple, and syndrome categories are described. Defects considered minor for the purposes of case classification are defined. Differences in the approach to case classification for studies of specific defects and of specific exposures are noted. CONCLUSIONS The case classification schema developed for the NBDPS may be of value to other clinicians working on epidemiologic studies of birth defects etiology. Consideration of these guidelines will lead to more comparable case groups, an important element of careful studies aimed at identifying risk factors for birth defects.

[1]  R. K. Miller,et al.  Postmarketing surveillance for human teratogenicity: a model approach. , 2001, Teratology.

[2]  N. Andreasen,et al.  Increased Incidence of a Midline Brain Anomaly in Patients With Nonsyndromic Clefts of the Lip and/or Palate , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[3]  K D Kochanek,et al.  Deaths: final data for 1999. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[4]  L D Edmonds,et al.  The National Birth Defects Prevention Study , 2001, Public health reports.

[5]  G. Zampino,et al.  Teratogenic Effects of Antiepileptic Drugs: Use of an International Database on Malformations and Drug Exposure (MADRE) , 2000, Epilepsia.

[6]  S. Bhattacharya,et al.  The genetics of childhood cataract , 2000, Journal of medical genetics.

[7]  E. Bermejo,et al.  Pathogenetic classification of a series of 27,145 consecutive infants with congenital defects. , 2000, American journal of medical genetics.

[8]  B. Källén,et al.  CHARGE Association in newborns: a registry-based study. , 1999, Teratology.

[9]  J. Seidman,et al.  Congenital heart disease caused by mutations in the transcription factor NKX2-5. , 1998, Science.

[10]  Marc S. Williams,et al.  CHARGE Association: An Update and Review for the Primary Pediatrician , 1998, Clinical pediatrics.

[11]  Edward B. Clark,et al.  Pathogenetic mechanisms of congenital cardiovascular malformations revisited. , 1996, Seminars in perinatology.

[12]  K. Jones,et al.  Smith's Recognizable Patterns of Human Malformation , 1996 .

[13]  M. Khoury,et al.  Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. , 1996, Pediatrics.

[14]  G. Shaw,et al.  Epidemiologic characteristics of conotruncal heart defects in California, 1987-1988. , 1996, Teratology.

[15]  R. Finnell,et al.  Biochemical and molecular teratology of fetal hydantoin syndrome. , 1994, Neurologic clinics.

[16]  I. Lurie,et al.  "Holoprosencephaly-polydactyly" (pseudotrisomy 13) syndrome: expansion of the phenotypic spectrum. , 1993, American journal of medical genetics.

[17]  H. Dolk,et al.  Registries of congenital anomalies: EUROCAT. , 1993, Environmental health perspectives.

[18]  M. Khoury,et al.  Is there etiologic heterogeneity between upper and lower neural tube defects? , 1992, American journal of epidemiology.

[19]  M. Khoury,et al.  Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens. , 1992, Teratology.

[20]  M. Khoury,et al.  Trends in rates of multiple vascular disruption defects, Atlanta, 1968-1989: is there evidence of a cocaine teratogenic epidemic? , 1992, Teratology.

[21]  M. I. Allen Structural anomalies resulting from vascular disruption. , 1992 .

[22]  M. Khoury,et al.  The interaction between dysmorphology and epidemiology: methodologic issues of lumping and splitting. , 1992, Teratology.

[23]  J. Friedman The use of dysmorphology in birth defects epidemiology. , 1992, Teratology.

[24]  M. Urioste,et al.  Value of clinical analysis in epidemiological research: the Spanish registry experience. , 1991, American journal of medical genetics.

[25]  H. Hoyme,et al.  Prenatal cocaine exposure and fetal vascular disruption. , 1990, Pediatrics.

[26]  K. Jones,et al.  Patterns of malformation in children with congenital diaphragmatic defects. , 1990, The Journal of pediatrics.

[27]  M. Khoury,et al.  Does maternal cigarette smoking during pregnancy cause cleft lip and palate in offspring? , 1989, American journal of diseases of children.

[28]  L. Holmes,et al.  Malformations due to presumed spontaneous mutations in newborn infants. , 1989, The New England journal of medicine.

[29]  M. Werler,et al.  Predictive value of minor anomalies. I. Association with major malformations. , 1987, The Journal of pediatrics.

[30]  M. Khoury,et al.  Exogenous sex hormone exposure and the risk for VACTERL association. , 1986, Teratology.

[31]  P. Fernhoff,et al.  Retinoic acid embryopathy. , 1985, The New England journal of medicine.

[32]  T. Bird,et al.  Dandy‐Walker malformation: etiologic heterogeneity and empiric recurrence risks , 1985, Clinical genetics.

[33]  L. Jorde,et al.  Phenotypic heterogeneity in neural tube defects: a clue to causal heterogeneity. , 1983, American journal of medical genetics.

[34]  M. Khoury,et al.  A population study of the VACTERL association: evidence for its etiologic heterogeneity. , 1983, Pediatrics.

[35]  J D Erickson,et al.  Etiologic heterogeneity of neural tube defects: clues from epidemiology. , 1982, American journal of epidemiology.

[36]  L B Holmes,et al.  Etiologic heterogeneity of neural-tube defects. , 1976, The New England journal of medicine.

[37]  E. Hook,et al.  Some aspects of the epidemiology of human minor birth defects and morphological variants in a completely ascertained newborn population (Madison study). , 1976, Teratology.

[38]  David W. Smith,et al.  Congenital anomalies in the newborninfant, including minor variations , 1964 .

[39]  P. M. Marden,et al.  CONGENITAL ANOMALIES IN THE NEWBORN INFANT, INCLUDING MINOR VARIATIONS. A STUDY OF 4,412 BABIES BY SURFACE EXAMINATION FOR ANOMALIES AND BUCCAL SMEAR FOR SEX CHROMATIN. , 1964, The Journal of pediatrics.

[40]  Y. Meurman Congenital microtia and meatal atresia; observations and aspects of treatment. , 1957, A.M.A. archives of otolaryngology.

[41]  N. Andreasen,et al.  Structural brain abnormalities in adult males with clefts of the lip and/or palate , 2002, Genetics in Medicine.

[42]  S. Rasmussen,et al.  Effective coding in birth defects surveillance. , 2001, Teratology.

[43]  J. Carey,et al.  Mild errors of morphogenesis. , 1996, Advances in pediatrics.

[44]  M. Khoury,et al.  On the use of the term "syndrome" in clinical genetics and birth defects epidemiology. , 1994, American journal of medical genetics.

[45]  M. Khoury,et al.  Monitoring for multiple congenital anomalies: an international perspective. , 1994, Epidemiologic reviews.

[46]  M. V. Van Allen Structural anomalies resulting from vascular disruption. , 1992, Pediatric clinics of North America.

[47]  J. Frías,et al.  Clinical/epidemiological analysis of malformations. , 1990, American journal of medical genetics.

[48]  M. Jones,et al.  Etiology of facial clefts: prospective evaluation of 428 patients. , 1988, The Cleft palate journal.

[49]  J. Opitz,et al.  Errors of morphogenesis: concepts and terms. Recommendations of an international working group. , 1982, The Journal of pediatrics.

[50]  M. Cohen The Child with Multiple Birth Defects , 1982 .